AnX Robotica Cut Capsule Endoscopy Review Time by 89%

New AI-assisted endoscopy software significantly accelerates small-bowel diagnostics compared to manual review.

Updated on Oct. 11, 2026 in Artificial Intelligence

Isometric editorial illustration of clean, geometric medical diagnostic pathways representing streamlined software efficiency.
AnX Robotica reported that its ProScan AI tool reduced mean small-bowel capsule endoscopy review time by nearly 89% in recent trials. AI Illustration. Upload story photo >

Live Poll

Do you trust artificial intelligence to assist doctors in diagnosing medical conditions accurately?

AnX Robotica reported that its NaviCam ProScan AI tool reduced mean small-bowel capsule endoscopy review time by 88.6%. The results, based on recent FDA filings, show a significant improvement over manual diagnostic workflows.

Why it matters

Reducing review time for capsule endoscopy enables faster clinical decision-making and allows providers to process more patient data efficiently. This performance metric establishes a new benchmark for AI-assisted image analysis in gastroenterology.

The NaviCam ProScan AI technology achieved an 88.6% reduction in mean small-bowel capsule review time. This figure notably outperforms a recently FDA-cleared comparator AI-assisted workflow, which demonstrated a 24.7% reduction in review time against manual processes.

The players

AnX Robotica

A Plano, Texas-based medical device company specializing in AI-assisted capsule endoscopy diagnostic platforms.

The details

The ProScan AI-assisted reading tool functions by automating the initial analysis of video data captured by endoscopic capsules. This process replaces manual capsule endoscopy reading, where a clinician must view hours of footage to identify abnormalities. By using proprietary algorithms to flag potential pathologies, the system accelerates the triage process for physicians examining the small bowel.

Timeline

  1. October 11, 2026: AnX Robotica released clinical performance results for its ProScan technology.

The Tech Race

The performance of the ProScan technology marks a substantial improvement over the efficiency standards set by earlier FDA-cleared AI-assisted capsule endoscopy tools. This result redefines expectations for image analysis speed within the diagnostic medical device sector.

Gastroenterology clinics in the United States may soon see faster diagnostic turnaround times for small-bowel imaging as this tool is implemented. Physicians can expect a shift in review workflows once these systems are integrated into standard clinical diagnostic practices.

The takeaway

The NaviCam ProScan performance data sets a new benchmark for AI efficiency in medical imaging. Industry stakeholders should monitor the adoption rate of this tool to see if the reduction in review time translates into improved patient outcomes.

Further reading

For broader trends in medical diagnostics, visit our Artificial Intelligence section.

Live Poll

Do you trust artificial intelligence to assist doctors in diagnosing medical conditions accurately?